| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2009 | EP2020403A1 Process for the resolution of zopiclone and intermediate compounds |
| 02/04/2009 | EP2019830A2 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 02/04/2009 | EP2019677A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/04/2009 | EP2019671A2 Bivalent smac mimetics and the uses thereof |
| 02/04/2009 | CN101360748A Inhibitors of c-met and uses thereof |
| 02/04/2009 | CN101360746A Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/04/2009 | CN101357924A Dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357923A Dipeptidase inhibitor compound |
| 02/04/2009 | CN101357922A New DPP-IV inhibitor |
| 02/04/2009 | CN101357921A New dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357915A Diazabicyclic central nervous system active agents |
| 02/04/2009 | CN101357134A Potenciador del efecto antitumoral y agente antitumoral |
| 02/04/2009 | CN100457756C Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 02/04/2009 | CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/03/2009 | US7485721 Oxidation resistance; antiinflamamtory agents; respiratory system disorders |
| 02/03/2009 | US7485661 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 02/03/2009 | US7485648 pyridine or pyrimidine thieno(2,3-e)pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 02/03/2009 | US7485640 e.g. 2'-fluoro-5'-(7-methyl-8-oxo-7,8-dihydroimidazo[1,2-a]pyrazin-3-yl)-biphenyl-2-carbonitrile; anticonvulsant |
| 02/03/2009 | US7485635 e.g. Methyl 3-[8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidzao[1,2-a][1,4]benzodiazepine-4-yl]propanoate; GABAA (gamma aminobutiric acid) receptor antagonist; sedative-hypnotic, anxiolytic, muscle relaxant and anticonvulsant; anesthesia |
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
| 02/03/2009 | CA2323150C New porphyrins and their use |
| 01/29/2009 | WO2009015254A1 Triazine kinase inhibitors |
| 01/29/2009 | WO2009013444A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 01/29/2009 | WO2009013335A1 Organic compounds |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | WO2009012573A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/29/2009 | WO2009012514A1 Phthalocyanine salts suitable for use in offset inks |
| 01/29/2009 | WO2008126105A3 Improved process for the preparation of zopiclone and it's enantiomerically enriched isomer |
| 01/29/2009 | WO2008116339A3 Organic compounds |
| 01/29/2009 | US20090030204 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same |
| 01/29/2009 | US20090030202 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 01/29/2009 | US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof |
| 01/29/2009 | US20090030014 Indole Derivative Having Pgd2 Receptor Antagonist Activity |
| 01/29/2009 | US20090030003 Amino-heterocyclic compounds |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029989 Substituted pyrazolopyrimidines |
| 01/29/2009 | US20090029982 Protein kinase inhibitors |
| 01/29/2009 | US20090029973 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029939 Pre-organized tricyclic integrase inhibitor compounds |
| 01/29/2009 | CA2694261A1 Organic compounds |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/29/2009 | CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | CA2693915A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 01/29/2009 | CA2693290A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/28/2009 | EP2019104A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 01/28/2009 | EP2019103A1 Novel compound having affinity for amyloid |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | EP2018383A1 Triazolopyrazine derivatives useful as anti-cancer agents |
| 01/28/2009 | EP2018167A2 Compositions and methods for fgf receptor kinases inhibitors |
| 01/28/2009 | CN101353350A Method for purifying haemachrome |
| 01/28/2009 | CN101353313A Process to produce oxazolidinones |
| 01/28/2009 | CN100456517C Use of axial substituted phthalocyanine compound for preparing organic thin film transistor |
| 01/28/2009 | CN100455584C Microwave assisted process of synthesizing tetraphenyl porphyrin inside ionic liquid |
| 01/27/2009 | US7482478 High trans-selectivities (up to >98%) and good yields (up to 99%) |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482360 Fused tetracyclic mGluR1 antagonists as therapeutic agents |
| 01/27/2009 | US7482356 Bicyclic pyrazolone cytokine inhibitors |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482345 P38 kinase inhibiting agents |
| 01/27/2009 | US7482338 Non-amide nonanes |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/27/2009 | CA2391871C Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 01/27/2009 | CA2345700C Process for the preparation of corroles and several such new compounds, including chiral derivatives, and the use thereof |
| 01/27/2009 | CA2335115C Fused azepinone cyclin dependent kinase inhibitors |
| 01/22/2009 | WO2009011787A1 Anti-viral compounds, compositions, and methods of use |
| 01/22/2009 | WO2009010925A2 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 01/22/2009 | WO2009010791A2 Cyclic ethers |
| 01/22/2009 | WO2009010530A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2008109177A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | WO2007136465A3 Compositions and methods for fgf receptor kinases inhibitors |
| 01/22/2009 | US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers |
| 01/22/2009 | US20090023921 such as dibenzoyl-L-tartaric acid salt of 1-cyclopentyl-3-(2,6-diethylpyridin-4-yl)propan-1-one |
| 01/22/2009 | US20090023920 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
| 01/22/2009 | US20090023919 Synthesis of temozolomide and analogs |
| 01/22/2009 | US20090023796 Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents |
| 01/22/2009 | US20090023776 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 01/22/2009 | US20090023758 Macrocyclic Inhibitors of Hepatitis C Virus |
| 01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023743 Inhibitors of protein kinases |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023738 Diaminopyrimidines as modulators of the ep2 receptor |
| 01/22/2009 | US20090023737 Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023724 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090022664 Radiolabelling via fluorination of aziridines |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2693793A1 Anti-viral compounds, compositions, and methods of use |